An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
DexCom, Inc. (NASDAQ:DXCM) will release its fourth quarter and full year 2021 financial results after market close on February 10, 2022. A conference call to discuss the results will follow at 4:30 p.m. ET. Investors can access the call via phone or through a webcast on the investor relations website.
Headquartered in San Diego, California, DexCom focuses on innovative continuous glucose monitoring systems to improve diabetes management.
Positive
Scheduled release of fourth quarter and full year 2021 financial results, indicating ongoing engagement with investors.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2021 financial results after market close on Thursday, February 10, 2022. Management will hold a conference call to review the company's fourth quarter and full year 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. investor relations website at investors.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (800) 446-1671 (US/Canada) or (847) 413-3362 (International) and use the confirmation number "50233346" approximately five minutes prior to the start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Investors
Sean Christensen Senior Director, Investor Relations and Corporate FP&A
(858) 203-6657
www.dexcom.com
Media
James McIntosh (619) 884-2118
Source: DexCom, Inc.
FAQ
When will DexCom release its fourth quarter and full year 2021 financial results?
DexCom will release its financial results on February 10, 2022.
What time is the DexCom conference call for Q4 and full year 2021 results?
The conference call will start at 4:30 p.m. ET on February 10, 2022.
How can I access the DexCom financial results conference call?
The call can be accessed by dialing (800) 446-1671 for US/Canada or (847) 413-3362 for international callers, using the confirmation number '50233346'.
Where can I find the webcast for DexCom's financial results?
The webcast will be available on DexCom's investor relations website.
